Lv4
610 积分 2023-11-04 加入
Complete CFTR gene sequencing in 5,058 individuals with cystic fibrosis informs variant-specific treatment
5个月前
已完结
Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based study
5个月前
已完结
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial
5个月前
已完结
Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients
5个月前
已完结
Oridonin: A small molecule inhibitor of cystic fibrosis transmembrane conductance regulator (CFTR) isolated from traditional Chinese medicine
6个月前
已完结
Progress in therapies for cystic fibrosis
7个月前
已完结
Direct Measurement of Trafficking of the Cystic Fibrosis Transmembrane Conductance Regulator to the Cell Surface and Binding to a Chemical Chaperone
7个月前
已完结
Clinical Phenotypes and Genotypic Spectrum of Cystic Fibrosis in Chinese Children
9个月前
已完结
Four case reports of Chinese cystic fibrosis patients and literature review
9个月前
已完结
Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients
9个月前
已完结
皖公网安备34019202002308
